Chemo-enzymatic synthesis of (-)-epipentenomycin I by Klomklao, Tawesin et al.
University of Wollongong 
Research Online 
Faculty of Science - Papers (Archive) Faculty of Science, Medicine and Health 
2003 
Chemo-enzymatic synthesis of (-)-epipentenomycin I 
Tawesin Klomklao 
Chiang Mai University 
Stephen G. Pyne 
University of Wollongong, spyne@uow.edu.au 
Apiwat Baramee 
Chiang Mai University 
Brian W. Skelton 
University of Western Australia 
Allan H. White 
University of Western Australia 
Follow this and additional works at: https://ro.uow.edu.au/scipapers 
 Part of the Life Sciences Commons, Physical Sciences and Mathematics Commons, and the Social 
and Behavioral Sciences Commons 
Recommended Citation 
Klomklao, Tawesin; Pyne, Stephen G.; Baramee, Apiwat; Skelton, Brian W.; and White, Allan H.: Chemo-
enzymatic synthesis of (-)-epipentenomycin I 2003. 
https://ro.uow.edu.au/scipapers/5318 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
Chemo-enzymatic synthesis of (-)-epipentenomycin I 
Abstract 
A chemo-enzymatic synthesis of (−)-epipentenomycin I is reported using a lipase-catalysed kinetic 
resolution of the racemic pentacyclic alcohol 8. Flash vacuum pyroloysis of (−)-8 so obtained gave (−)-
(4R)-4-hydroxy-5-methylene-2-cyclopentenone. Epoxidation of this compound with dimethyldioxirane 




Life Sciences | Physical Sciences and Mathematics | Social and Behavioral Sciences 
Publication Details 
Pyne, S. G., Klomklao, T., Baramee, A., Skelton, B. W. & White, A. H. (2003). Chemo-enzymatic synthesis of 
(-)-epipentenomycin I. Tetrahedron-Asymmetry, 14 3885-3889. 
This journal article is available at Research Online: https://ro.uow.edu.au/scipapers/5318 
Page-1 
 
Chemo-Enzymatic Synthesis of (-)-Epipentenomycin I 
 
 
Tawesin Klomklao†, Stephen G. Pyne§*, Apiwat Baramee†, 
Brian W. Skelton‡ and Allan H. White‡ 
 
Department of Chemistry, Chiang Mai University, Chiang Mai 50202, Thailand,  
Department of Chemistry, University of Wollongong, Wollongong, NSW, 2522, Australia, and 





Abstract: A chemo-enzymatic synthesis of (-)-epipentenomycin I is reported using a lipase 
catalysed kinetic resolution of the racemic pentacyclic alcohol 8.  Flash vacuum pyroloysis of (-)-
8 so obtained gave (-)-(4R)-4-hydroxy-5-methylene-2-cyclopentenone. Epoxidation of this 
compound with dimethyldioxirane followed by hydrolytic ring-opening of the resulting epoxide 
gave (-)-epipentenomycin I.   
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The pentenomycin group of natural products (compounds 1-4) have antibacterial activities 
against both Gram-positive and Gram-negative bacteria.  Pentenomycins I (1) and II (2) were first 
isolated from Streptomyces eurythermus in 19731 while pentenomycin III (3) was isolated three 
years later from Streptoverticillium eurocidicum.2  Epipentenomycin I (4), however, was isolated in 
19893a from carpophores of Perziza sp., much later than its first synthesis in racemic form in 
1980.4,5  This compound was shown to have the (4S, 5R) absolute configuration by X-ray 
crystallographic analysis of its 2-bromo-O-triacetate derivative.3b Thus establishing that 
pentenomycin I (1) and epipentenomycin I (4) are epimeric at C-5.   Their biological activities and 
their highly oxygenated structures have attracted several synthetic studies on their total synthesis,6 
the synthesis of their racemates4,5,7 and their analogues8 (e.g. epipentenomycin II (5) and III (6)).  
We recently reported a diastereoselective synthesis of ()-epipentenomycin I (4) and III (6) from 
the diastereoselective epoxidation of 4-hydroxy- and 4-acetoxy-5-methylene-2-cyclopentenone, 
respectively, with dimethyldioxirane followed by hydrolytic ring-opening of the resulting 










1; pentenomycin  (R1 = R2 = H)
2; pentenomycin  (R1 = Ac, R2 = H)
3; pentenomycin (R1 = H, R2 =Ac)
4; epipentenomycin  (R1 = R2 = H)
5; epipentenomycin  (R1 = Ac, R2 = H)
6; epipentenomycin (R1 = H, R2 =Ac)  
 
The known racemic epoxide, rac-79 (a 1.6 : 1 mixture of diastereomers), was converted to a mixture 
the known racemic alcohols rac-8 and rac-10 (Scheme 1).9  These isomers could be obtained pure 
after separated by column chromatography and recrystallization.  The relative stereochemistry of 
these compounds was determined by NOESY experiments and single crystal X-ray analysis on their 
corresponding acetates rac-9 and rac-11, respectively.10  NOESY studies on rac-9 showed cross-
peaks between the allylic proton Ha and the benzylic methine Hb, while in rac-11, cross-peaks 
were observed between the allylic proton Hb and one methylene proton Ha (Scheme 1).  Kinetic 
resolution of rac-8 was achieved using PS-D ‘Amano’ I lipase on celite and vinyl acetate (6 equiv) 
in acetonitile at 40 oC. After 101 h the reaction was terminated at 41% conversion.11  The reaction 
mixture was separated by column chromatography to provide acetate (-)-9 ([]D24 –189 (c 2.03, 
CHCl3)), in 37% yield and in greater than 98% enantiomeric purity, and the alcohol (+)-8 in 53% 
yield and 68% enantiomeric purity, as determined on its acetate (+)-9.  The enantiomeric purities of 
(-)-9 and that of (+)-9 were determined by 1H NMR using the chiral shift reagent, europium tris[3-
(heptafluoropropylhydroxymethylene)-(+)-camphorate] (Eu(hfc)3).   
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While base catalysed hydrolysis (K2CO3, MeOH) of acetate (-)-9 resulted in Michael addition of 
methanol to the enone of (-)-8, acid catalysed hydrolysis using aqueous trifluoroacetic acid in 
acetonitile smoothly gave the desired alcohol (-)-8 ([]D24 –120 (c 1.28, CHCl3)) in excellent yield 
(96%) (Scheme 1).   

















rac-8 (-)-9, R = Ac
(-)-8 R = H
(+)-8, R = H
(+)-9, R = Ac
+
rac-10, R = H
rac-11, R = Ac
rac-8, R = H








aReagents and conditions: (a) Et3N, CH2Cl2, 0 
0C to RT, 16 h. 
(b) Ac2O, pyridine. (c) PS-D ‘Amano’ I lipase on celite, vinyl 
acetate, MeCN, 40 oC, 101 h. (d) TFA, MeCN, H2O, 60 
oC 16 h. 
 
Flash vacuum pyrolysis of (-)-8 at 450 oC and < 0.1 mm Hg gave (-)-(4R)-4-hydroxy-5-methylene-
2-cyclopentenone, (-)-12, in 76% yield.  Treatment of this compound with freshly distilled 
dimethyldioxirane (DMDO) in acetone12 at RT for 12 h produced an 83 : 17 mixture of the anti- 
and syn-epoxy-alcohols, respectively.  The crude mixture was separated by flash chromatography to 
give about a 90 : 10 mixture of these isomers. Recrystallization of this mixture gave pure (-)-(3S, 
7R)-13 in 39% yield (mp 94-95 oC) from which single crystals were obtained. X-ray 
crystallographic analysis (supporting information) confirmed our earlier NOESY NMR experiments 
that the major diastereomer resulted from epoxidation of (-)-12, anti to the allylic hydroxy 
group.7c,10   
Heating a solution of (-)-13 in water7c,13 in a sealed tube at 80 oC, with monitoring by 1H NMR 
spectroscopy, cleanly led to ring-opening of the epoxide group. After freeze-drying (-)-
epipentenomycin I, (-)-4 was obtained in 86% yield (Scheme 2).  This sample had identical spectral 
characteristics to those reported in the literature for (+)-4,3b,7a however its specific rotation was 
opposite in sign ([]D26 –75 (c 1.15, MeOH), lit.3b ([]D23 + 35.3 (c 2.6, MeOH)) and larger in 
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magnitude than the literature value.  This discrepancy in the magnitude of the specific rotations 
may be due to the hydroscopic nature of these compounds and therefore (-)-4 was converted to the 
known and less hydroscopic triacetate (-)-14 (Scheme 2).  This sample had identical spectral 
characteristics to those reported in the literature for (+)-14, 3b,7a and the magnitude of its specific 
rotation was similar to the literature value ([]D26 –55 (c 1.16, MeOH), lit.3b ([]D23 + 47 (c 0.21, 
MeOH)).   
In conclusion we have developed an efficient chemo-enzymatic synthesis of (-)-epipentenomycin I 
using a lipase catalysed kinetic resolution of the racemic pentacyclic alcohol rac-8.  The chiral 
chemical intermediates described here should be valuable for the synthesis of other bioactive 


















26 -163  (c 1.24, CHCl3)
(-)-8
(-)-(3S, 7R)-13, dr = 83 : 17
[]D


















aReagents and conditions: (a) FVP (450 oC, < 0.1 mm Hg).  (b) 
dimethyldioxirane, acetone, -78 oC to RT. 16 h. (c) H2O, 80 




General Remarks. All NMR spectra were determined in solutions of CDCl3 at 300 MHz (
1H 
NMR) or 75 MHz (13C NMR) unless otherwise stated. NMR assignments are based upon 2D NMR 
spectral analysis (COSY and DEPT).  Lipase used in this experiment was PS-D Amano I 
(immobilized PS-D “Amano” I lipase on celite) from Amano Enzyme Inc., Japan. To determine the 
enantiomeric purities of the enzymaticaly resolved alcohols, they were converted in to their acetates 
9 with acetic anhydride/pyridine. The enantiomeric excess was determined by 1H NMR using the 
chiral shift reagent, europium tris[3-(heptafluoropropylhydroxymethylene)-(+)-camphorate]. The 
acetate 9 (5.0 mg) was dissolved in 0.7 mL of a solution of Eu(hfc3) (14.8 mg) in CDCl3 (5.0 mL). 
The acetate signals of (+)-9 and ()-9 were at δ 1.877 and 1.872 respectively.   
9',10'-Dihydro-5-hydroxy-spiro[3-cyclopenten-1,11'-(9,10)ethanoanthracene]-2-one (rac-8 and 
rac-10). To a solution of the crude epoxide (rac-7)9 (dr = 1.6:1 was indicated by 1H NMR) (1.50 g, 
5.21 mmol) in dry CH2Cl2 (20 mL) at 0
 ˚C was added triethylamine (1.5 mL, 10.42 mmol) and the 
resulting mixture was stirred at RT overnight. Solvents were evaporated to dryness and the 
diastereomeric alcohols were separated by column chromatography on silica gel (CH2Cl2: 
petroleum spirit ; 9 : 1  as the eluent). Recrystallization from CH2Cl2 and petroleum spirit gave rac-
8  (0.843 g, 2.927 mmol) and rac-10 (0.552 g, 1.9167 mmol). rac-8: White crystals, m.p. 162-
163˚C (from CH2Cl2/Petroleum Spirit) (lit.
14 163-165˚C, from CH2Cl2/hexane). IR (CHCl3), υmax, 
3415, 3025, 2933, 1709, 1460, 1170, 763 cm –1. 1H NMR δ 0.86  (br d, OH, 1H), 1.78, 2.30, 4.40 
(ABX system, JAB = 12.7Hz, JAX = JBX = 2.5 Hz, 3H), 3.99 (s, 1H), 4.57-4.60 (m, 1H), 6.19 (dd, J = 
7.5, 1.5 Hz, 1H), 7.05-7.50 (m, 9H). 13C NMR δ 34.3, 44.5, 52.1, 56.7, 78.2, 123.0, 124.2, 124.7, 
125.9, 126.0, 126.3, 126.5, 126.8, 134.2, 139.8, 141.6, 144.5, 144.6, 160.0, 208.3. LRMS (CI +ve) 
(isobutane): 288 [M]+ (2%), 178 [C14H10]
+ (100%). HRMS (CI +ve) Calcd for C20H16O2 [M]
+ 
288.115082.  Found: 288.115030.  rac-10: White crystals, m.p. 159-160˚C (from CH2Cl2/hexane) 
(lit.14 159-160˚C from CH2Cl2/hexane). IR (CHCl3), υmax, 3450, 3030, 2933, 1710, 1680, 1440, 
1325, 765 cm -1 . 1H NMR δ 2.09 (br d, OH, 1H), 1.73, 2.04, 4.38 (ABX system, JAB = 12.3 Hz, JAX 
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= JBX = 2.7 Hz, 3H), 4.23-4.25 (m, 1H), 4.35-4.37 (m, 1H), 6.19 (dd, J = 6, 0.9 Hz, 1H), 7.06-7.43 
(m, 9H). 13C NMR δ 41.0, 44.4, 47.7, 56.3, 81.0, 122.9, 123.8, 125.2, 125.5, 125.7, 125.8, 126.0, 
126.2, 134.7, 140.3, 141.7, 143.9, 145.0, 159.0, 207.3.  
Kinetic resolution of 9',10'-Dihydro-5-hydroxy-spiro[3-cyclopenten-1,11'-
(9,10)ethanoanthracene]-2-one (rac-8). To a solution of rac-8 (1.000 g, 3.47 mmol) and vinyl 
acetate (1.9 mL, 20.82 mmol) in acetonitrile (35 mL) was added immobilized PS-D “Amano” I 
Lipase on celite (2.000 g). After 101 h at 40˚C, with stirring at 400 rpm, 41% conversion was 
calculated from the enantiomeric excess of the starting alcohol (8) and the acetate (9) according to 
% Conv. = 68 /(68+98) = 41.11 The reaction mixture was diluted in CH2Cl2, filtered through a plug 
of celite and evaporated to dryness. The crude mixture was purified by column chromatography on 
silica gel. Elution with 30% petroleum spirit in CH2Cl2 gave the acetate ()-9 (0.42 g, 37%, ee 
>98%). The column was then stripped with 20% EtOAc in CH2Cl2 to obtain the alcohol (+)-8 (0.53 
g, 53%, ee = 68%). The alcohol (+)-8 (0.53 g) was recrystallized from CH2Cl2/ petroleum spirit to 
obtain (+)-8 (0.33 g, 33%, ee >98%). (+)-8: White crystals, m.p. 166-167˚C (from CH2Cl2 / 
petroleum spirit). [α] 24D  + 119.7˚ (c = 1.98; CHCl3), ee >98%.  Spectral data were identical to rac-8.  
()-9: White crystals; m.p. 210-211˚C (from CH2Cl2/ petroleum spirit), [α] 24D  189.2˚ (c = 2.03, 
CHCl3), ee >98%. 1H NMR: δ 1.74 (s, 3H), 1.89, 2.11, 4.38 (ABX system, JAB = 12.7 Hz, JAX = JBX 
= 2.4 Hz, 3H), 3.99 (s,1H), 5.49 (dd, J = 2.7, 1.2 Hz,1H), 6.30 (dd, J = 6.0, 0.6 Hz, 1H), 7.11-7.33 
(m, 8H), 7.45 (dd, J = 6.0, 2.7 Hz, 1H). 
13C NMR δ 20.6, 34.5, 44.5, 52.4, 55.3, 78.8, 123.1, 123.8, 
125.2, 125.9, 126.3, 126.7, 126.8, 135.6, 139.6, 140.9, 144.3, 144.6, 156.6, 169.8, 207. LRMS (CI 
+ve) (isobutane): 331 [M+H]+ (7%), 271 (65%), 179 [C14H10 + H]
+(100%). HRMS (CI +ve) Calcd 
for C22H18O3(M)
+  330.124909.  Found: 330.125595. 
 ()-9',10'-Dihydro-5-hydroxy-spiro[3-cyclopenten-1,11'-(9,10)ethanoanthracene]-2-one (()-
8).  To a solution of ()-9 (372 mg, 1.125 mmol) in CH3CN/H2O (3 : 1, 16 mL) was added TFA 
(2.9 mL, 3.94 mmol). The reaction mixture was then heated overnight at 60 ˚C. The aqueous layer 
was extracted with CH2Cl2 (3 x 15 mL) and the organic layers were washed with water, brine and 
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dried (MgSO4). The solvent was evaporated to dryness and the residue was purified by flash 
column chromatography on silica gel using 20% EtOAc in CH2Cl2 as the eluent to give the alcohol 
()-8 (311 mg, 96%). ()-8: white crystals; m.p. 162-163 ˚C (CH2Cl2/pretoleum spirit), [α] 27D  ˚ 
(c = 1.28; CHCl3). Spectral data were identical to rac-8.   
()-(4R)-4-Hydroxy-5-methylene-2-cyclopentenone ((-)-12). Compound ()-8 (390 mg, 1.354 
mmol; 30 mg was used each time) was placed in 10 mL round-bottom flask connected to a gas 
phase pyrolysis apparatus and the system was subjected to high vacuum (< 0.1 mm Hg). The 
sample was carefully pyrolysed with heat gun and the vapour passed through the heating column at 
450 ˚C. The crude product was purified by flash column chromatography on silica gel, elution with 
petroleum spirit gave ()-12 (113.9 mg, 76%) that was homogeneous from TLC and NMR analysis.  
This compound was used immediately in the next step or could be stored for a few days in the 
freezer without noticeable polymerization. ()-12: viscous liquid, [α] 26D  163.3˚  (c = 1.24, CHCl3), 
IR (neat) υmax 3403, 2876, 1705, 1579, 1400, 895 cm-1. 1H NMR δ 2.42- 2.56 (br, OH, 1H), 5.22 (d, 
J = 7.5 Hz, 1H), 5.76 (s, 1H), 6.20 (s, 1H), 6.45 (dd, J = 6.5, 0.9 Hz, 1H), 7.54 (ddd, J = 6.0, 2.4, 0.9 
Hz, 1H). 13C NMR δ 70.7 (C-4), 119.0 (C-6), 136.2 (C-2), 145.1 (C-5), 159.6 (C-3), 194.8 (C-1). 
CIMS (isobutane): 111 [M+H]+ (100%). 
 ()-(3S, 7R)-7-Hydroxy-1-oxaspiro[2.4]hept-5-en-4-one ((-)-13). To a solution of ()-12 (62.1 
mg, 0.565 mmol) in acetone (5 mL) was added a solution of freshly distilled dimethyldioxirane (21 
mL, 1.491 mmol) in acetone at 78˚C and the reaction was left to stir overnight at room 
temperature. The solvent was then evaporated to dryness. The crude product (dr = 83:17  from 1H 
NMR analysis) was purified by flash column chromatography on silica gel using 10% EtOAc in 
petroleum spirit as the initial eluent followed by 20% EtOAc in petroleum sprit. Recrystallization 
from CH2Cl2 in the freezer (-20 
oC) gave pure ()-13 (28 mg, 39%). ()-13: white crystals; m.p. 94-
95 ˚C (from CH2Cl2), [α]
26
D  159.6 
o (c =1.03; CHCl3),
 1H NMR δ 2.51 (br d, J = 7.5 Hz, OH, 1H), 
3.14 (d, J = 6.6 Hz, 1H), 3.29 (d, J = 6.9 Hz,1H), 4.95 (br dd, J = 7.2, 1.2 Hz, 1H), 6.52 (dd, J = 6.3, 
1.5 Hz, 1H), 7.70 (dd, J = 6.3, 2.4 Hz, 1H).
 13C NMR δ 51.1 (C-2), 64.2 (C-3), 71.0 (C-7), 135.9 (C-
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5), 161.8 (C-6), 199.8 (C-4). LRMS (CI +ve) (isobutane): 127 [M]+ (100%), 109 [M-H2O]
+ (37%), 
81 (15%). HRMS (CI +ve) Calcd for C6H7O3(M)
+ 127.040235.  Found: 127.039519. 
 ()-(4R, 5S)-Epipentenomycin I (()-4). A solution of ()-13 (14.5 mg, 0.115 mmol) in H2O (0.5 
mL) was heated overnight at 80 ˚C. The water was then evaporated under vacuo to obtain ()-4 
(14.3 mg, 86%) that was pure by TLC and NMR analysis. (-)-4: viscous liquid [α] 26D  75.3˚ (c = 
1.15; MeOH), IR (neat) υmax, 3381, 2928, 2532, 1711, 1657, 1253, 1058, 840 cm-1. The 1H and 13C 
NMR of this compound was identical to that reported in the literature.3  1H NMR (D2O): δ 3.71 (d, J 
= 11.7 Hz, 1H), 3.82 (d, J = 12 Hz, 1H), 4.86 (m, 1H), 6.41 (dd, J = 6.3, 1.5 Hz), 7.73 (dd, J = 6.3, 
2.1 Hz). 13C NMR (D2O + MeCN as internal standard): δ 63.6 (C-6), 77.5 (C-4), 82.4 (C-5), 132.5 
(C-2), 163.8 (C-3), 208.5 (C-1). LRMS (CI +ve): 145 [M]+ (100%), 127 [M-H2O]
+ (26%). HRMS 
(CI +ve) Calcd for C6H9O4(M)
+ 145.050356.  Found: 145.050084. 
()-(4R, 5S)-Epipentenomycin I triacetate ((-)-14). A solution ()-4 (11.3 mg, 0.079 mmol) in 
pyridine (2 mL) was added excess acetic anhydride at room temperature and the reaction mixture 
was left to stir overnight. The solvents were then evaporated to dryness. The crude product was 
purified by flash column chromatography on silica gel using 30% EtOAc in petroleum sprit as the 
eluent to obtain ()-14 (18.7 mg, 88%). ()-14: viscous liquid, [α] 26D   55.1˚ (c = 1.16; MeOH) lit.
3 
[α] 23D   + 47.5˚ (c = 0.64; MeOH) IR (neat) υmax 2923, 2360, 1735, 1374, 1214, 1054 cm
-1. The 1H 
and 13C NMR of this compound was identical to that reported in the literature.3  1H NMR δ 2.14, 
2.13 and 2.04 (s, 3 × 3H), 4.07 (d, J = 11.7 Hz, 1H), 4.52 (d, J = 12 Hz, 1H), 6.26 (m, 1H), 6.49 
(dd, J = 6.3, 1.8 Hz, 1H), 7.38 (dd, J = 6.3, 2.4 Hz, 1H). 13C NMR δ 197.3 (C-1), 170.2, 170.1 and 
170.0 (CO-acetyls), 155.0 (C-3), 134.9 (C-2), 82.8 (C-5), 77.2 (C-4), 62.5 (C-6), 20.8 (Me-acetyls). 
LRMS (CI +ve): 271 [M]+ (100%). HRMS (CI +ve) Calcd for C12H15O7(M)




Acknowledgments We thank the Universities of Wollongong and the Graduate School Chiang Mai 
University for partial financial support and Toyoko Iwata from Amano Enzyme Inc., Nagoya, Japan 
for the generous gift of lipase enzymes. 
 
Supporting Information Available. Copies of the 1H and 13C NMR spectra of compounds 4 and 8-
13, 1H NMR spectra of rac- and (-)-9 with the chiral shift reagent, NOESY spectra of 9 and 11, the 
ORTEP plots of 9, 11 and (-)-13 and data for the crystal structure of (-)-13.  This material is 




1.  Umino, K.; Furumai, T.; Matsuzawa, N.; Awataguchi, Y.; Ito, Y.; Okuda, T. J. Antibiot. 1973, 
26, 506.  
2.  Shomura, T.; Hoshida, J.; Kondo, Y.; Watanabe, H.; Omoto, S.; Inouye, S.; Niida, T. Kenyu 
Nempo 1976, 16, 1. 
3.  (a) Bernillon, J.; Bonvin, J. F.; Pommier M. T.; Arpin, N. J. Antibiot. 1989, 13, 1430. (b) Baute, 
M.-A.; Deffieux, G.; Baute, R.; Badoc, A.; Vercauteren, J.; Leger, J.-M.; Neveu, A. Phytochem. 
1991, 30, 1419. 
4.  Smith III, A. B.; Pilla, N. N. Tetrahedron Lett. 1980, 21, 4691. 
5. Shono, T.; Matsumura, Y.; Yamane, S.; Suzuki, M. Chem. Lett. 1980, 1619. 
6. (a) Elliott, J. D.; Hetmanski, M.; Palfreyman, M. N.; Purcell, N.; Stoodley, R. J. Tetrahedron 
Lett. 1983, 24, 965. (b) Hetmanski, M.; Purcell, N.; Stoodley, R. J.; Palfreyman, M. N. J. Chem. 
Soc. Perkin Trans. I. 1984, 2089. (c) Sugahara, T.; Ogasawara, K. Synlett 1999, 419. (d) 
Seepersaud, M.; Al-Abed, Y. Tetrahedron Lett. 2000, 41, 4291. (e) Gallos, J. K.; Damianou, K. 
C.; Dellios, C. C. Tetrahedron Lett. 2001, 42, 5769. 
7. (a) Smith III, A. B.; Branca, S. J.; Pilla, N. N.; Guaciaro, M. A. J. Org. Chem. 1982, 47, 1855. 
(b) Pohmakotr, M.; Popuang, S. Tetrahedron Lett. 1991, 32, 275. (c) Phutdhawong, W.; Pyne S. 
G.; Baramee A.; Skelton, B. W.; White, A. H. Tetrahedron Lett. 2002, 43, 6047. 
8. (a) Verlaak, J. M. J.; Klunder, A. J. H.; Zwanenburg, B. Tetrahedron Lett. 1982, 23, 5463. (b) 
Klunder, A. J. H.; Houwen-Claassen, A. A. M.; Kooy, M. G.; Zwanenburg, B. Tetrahedron Lett. 
1987, 28, 1329. (c) Houwen-Claassen, A. A. M.; Klunder, A. J. H.; Zwanenburg, B. Tetrahedron 
1989, 45, 7134. 
9. Chantarasiri, N.; Dinprasert, P.; Thebtaranonth, C.; Thebtaranonth, Y.; Yenjai, C. J. Chem. Soc. 
Chem. Commun. 1990, 286. 
10.  rac-9 and rac-11 correspond to structures 12a (CCDC# 184071) and 12b (CCDC# 184072) of 
ref.7c (crystal/refinement details not given in ref.7c). For these two isomers of C22H18O3, Mr = 
330.4 at ca 153 K. rac-9: Monoclinic, space group P21 (note that although this space group is 
chiral, the bulk sample is racemic), a = 8.132(1), b = 9.697(1), c = 10.898(2) Å,  = 103.344(4)°, 
V = 836 Å3, Z = 2.  R = 0.050, Rw = 0.051, for No = 1671 CCD reflections (F > 4(F)), Mo K 
radiation) (chirality indeterminate) (CCDC# 184071). rac-11: Monoclinic, P21/c (i.e. racemic 
specimen), a = 9.592(2), b = 17.638(4), c = 10.078(2) Å,  = 103.265(4)°, V = 1160 Å3, Z = 4.  R 
= 0.049, Rw = 0.056, for No = 1981 (CCDC# 184072)).  (-)-13 is monoclinic, P21, a = 6.906(3), 
b = 10.971(4), c = 7.212(3) Å,  = 95.157(6)°, V = 544 Å3, Z = 4.  R = 0.086, Rw = 0.010, for No 
= 1176 (CCDC# 212132).  The chirality adopted is assigned from chemistry.  The material was 
Page-11 
'difficult', presumably in consequence of the packing of the molecules in strings, each made up 
of symmetry-related sequences of the independent components molecule 1 or molecule 2 of the 
asymmetric unit, linked by hydrogen-bonds between the hydroxyl hydrogen of one molecule and 
the ketonic oxygen of the next. 
11. The percentage conversion was calculated from the enantiomeric excess of the starting 
alcohol (8) and acetate (9) according to % conv. = 68 /(68+98) = 41. See: Chen, Ch. Sh.; 
Fujimoto, Y.; Girdaukas, G.; Sih, J. C. J. Am. Chem. Soc. 1982, 104, 7294. 
12. Murray, R. W.; Singh, M. Org. Synth. 1997, 74, 91. 
13. For the ring-opening of an epoxide with water see: Lubineau, A.; Billault, I. Carbohydr. 
Res. 1999, 320, 49. 
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